Metrigraphics has been acquired by Cirtec Medical Corp.
Metrigraphics, a portfolio company of New England Capital Partners and Clarkston Merchant Partners, has been sold to Cirtec Medical, a portfolio company of 3i Group plc (LSE:III).
Metrigraphics is a leading manufacturer of ultra-high precision, custom micron-scale medical device components for growing markets including continuous glucose monitoring, advanced drug delivery, active medication management and life science instruments.
Cirtec Medical engages in the outsourced design, engineering, development and manufacturing of class II and III medical devices. The company develops product platforms for neuromodulation, implantable drug delivery, cardiac rhythm management, ventricular assist devices and minimally invasive surgical systems. It also provides product development services ranging from concept to commercialization, which include program management, design and development, clinical build and regulatory support, and assembly and manufacturing, as well as flexible product transfer programs to allow relocation or duplication of product manufacturing lines to help expand manufacturing capacity, optimize yields and reserve capital. The company serves medical device companies that range from large manufacturers to small startups around the world.
One of Oaklins’ teams in the USA served as the exclusive financial advisor to Metrigraphics in this transaction.


Talk to the deal team
Michael S. Goldman
Oaklins TM Capital
Craig M. Gibson
Oaklins TM Capital
James McLaren
Oaklins TM Capital
Related deals
Bolster Investment Partners has acquired a majority stake in Eternal Sun
Bolster Investment Partners, a Netherlands-based investment firm, has acquired a majority stake in Eternal Sun, a global technology leader in advanced solar panel testing equipment, from ABN AMRO Sustainable Impact Fund, a private impact fund based in the Netherlands, and Vermec, a Belgium-based investment firm.
Learn moreCerbios-Pharma has been acquired by HAS Healthcare
Cerbios-Pharma S.A. has been acquired by HAS Healthcare Advanced Synthesis S.A., forming a leading global contract development and manufacturing organization (CDMO) group. This transaction results in a seamless integration of complementary capabilities, combining extensive expertise in production, chemical and biological sciences and technical excellence, all designed to meet the evolving demands of the global pharmaceutical sector.
Learn moreBriconord has completed its fourth LBO with ODDO BHF
Briconord, a French designer and distributor of furniture and hardware solutions, has been acquired by a consortium of investors led by ODDO BHF in its fourth leveraged buyout (LBO).
Learn more